Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury
Abstract Spinal cord injury (SCI), characterized by the disruption of neural pathways and an increase in inflammatory cell infiltration, leads to profound and lasting neurological deficits, with a high risk of resulting in permanent disability. Currently, the therapeutic landscape for SCI is notably...
Saved in:
Main Authors: | Haoru Dong, Zongxing He, Shiyi Cai, Haiqiang Ma, Lili Su, Jianfeng Li, Huiying Yang, Rong Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-025-03153-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Critical Management of Spinal Cord Injury: A Narrative Review
by: Emilio Moreno-González, et al.
Published: (2024-12-01) -
Evaluation of the Chetomin effect on histopathological features in a murine acute spinal cord injury model
by: Carlos César Bravo-Reyna, et al.
Published: (2025-01-01) -
Evaluation of transcriptomic changes after photobiomodulation in spinal cord injury
by: Andrew R. Stevens, et al.
Published: (2025-01-01) -
Multi-omics uncovers immune-modulatory molecules in plasma contributing to resistance exercise-ameliorated locomotor disability after incomplete spinal cord injury
by: Ren Zhou, et al.
Published: (2025-02-01) -
Paralyzing paradox: Spinal cord infarction, a hidden emergency
by: Khurram Khaliq Bhinder, et al.
Published: (2025-04-01)